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Objective: The purpose of this study was to determine whether amnion-derived cellular
cytokine solution (ACCS) could improve the quality of epithelialization and accelerate
closure of dermatome-created partial-thickness wounds in normal and streptozotocin-
induced diabetic pigs. Methods: Dermatome-created partial-thickness wounds were
sealed with wound chambers in healthy and diabetic pigs and were injected with ACCS.
Woundﬂuidwasexchangeddailyfortotalproteinconcentration,andbiopsiesweretaken
on days 6, 8, 10, and 12. Epithelialization, thickness of epidermis, number of epidermal
cell layers, and rete ridges were evaluated. Results: The macroscopic appearance of the
wounds and speed of healing was similar in all groups at each time point. All wounds
were healed by day 6. The epidermis was thicker in the ACCS-treated diabetic wounds
than in the controls (140.6 μm vs 82.7 μm on day 12 in diabetic pigs). There were more
celllayers(13vs7.7)inACCS-treateddiabeticpigsonday12.Thenumberofreteridges
per 2.5 mm was greater on day 12 in the ACCS-treated diabetic wounds (13 vs 8). There
was also a signiﬁcant increase in the number of rete ridges in ACCS-treated nondiabetic
pigs but no difference in epidermal thickness or number of cell layers. Conclusion:
In diabetic pigs, we found a signiﬁcantly thicker epidermis and more cell layers and
rete ridges in the ACCS-treated wounds. Healthy pigs showed more rete ridges but no
difference in thickness of epidermis or number of cell layers on day 12.
Stem cells or stem cell–like multipotent cells have great potential in the wound heal-
ing/tissue repair arena.1. They have the ability to differentiate into the various cell types of
the repair process and to secrete the humoral messengers necessary to mediate the cellular
processes.2−4 Adult stem-like cells derived from amnion have been shown to secrete many
cytokines and growth factors.5−7
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Amnion-derived multipotent progenitor (AMP) cells have been reported to increase
the rate of gain of incisional breaking strength and decrease the incidence and severity
of acute wound failure.8 It was postulated that one of the possible mechanisms for the
improvement of acute wound healing in these experiments was that the AMP cells could
be making the necessary cytokine cocktail at the proper time and dose to affect a trajectory
shift.8 The secreted cytokines from AMP cells have been labeled amnion-derived cellular
cytokine solution (ACCS) and studied using qualitative antibody arrays, enzyme-linked
immunosorbent assay (ELISA), multiplex expression analysis, and mass spectroscopy.9
The solution was found to contain a combination of cytokines and growth factors at
physiological levels. There was a good correlation between the levels of cytokines in ACCS
and available levels of cytokines reported in the literature as measured in humans in normal
and diseased states.9 Topical application of ACCS has been reported to accelerate wound
closure of experimental chronic-infected granulating wounds.1
The purpose of the present study was to evaluate the effects of local application of
ACCS in a wound-healing model of epithelialization. The model is a partial-thickness skin




ACCS was prepared by Stemnion, Inc (Pittsburgh, Pennsylvania) as follows: amnion-
derived cells were dissociated from the amnion of donated, full-term, scheduled C-section
placentae. AMP cells, a subpopulation of multipotent cells selected from amnion-derived
cells, were used to produce ACCS. Once isolated from the placenta and selected, AMP
cells were grown to conﬂuency in STM100, a proprietary cell media. Cell cultures reached
conﬂuency in 7 to 9 days, and the ACCS was harvested on days 12 and 15.9
Design of the study
In the ﬁrst part of the experiment, 72 partial-thickness wounds were created on the backs of
3 female healthy Yorkshire pigs. Twenty-four wounds were received treatment with 1-mL
ACCSand1-mLsalinecontaining200unitsofpenicillinand200mgofstreptomycinplaced
in the wound chamber every other day (group ACCS qod). Another 24 wounds received
the same amount of ACCS and saline with antibiotics but every 4 days (group ACCS q4d).
The 24 control wounds received 2 mL of saline with 100 units of penicillin and 100 mg of
streptomycin per milliliter. The wound ﬂuid was processed for total protein concentration
as a noninvasive parameter for reestablishment of the epithelial barrier function. Biopsies
were taken on days 6, 8, 10, and 12. Specimens were ﬁxed in 10% neutral buffered formalin
and processed for hematoxylin and eosin staining. Average thickness of the epidermis and
the number of cell layers were recorded.
In the second part of this study, the same size and number partial-thickness wounds
were created on the backs of 3 diabetic pigs. Experimental wounds consisted of 5 groups
receiving incremental dilutions of ACCS (0.445-mL ACCS/cm2, 0.255-mL ACCS/cm2,
0.111-mL ACCS/cm2, 0.045-mL ACCS/cm2, and 0.022-mL ACCS/cm2). Wounds treated
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with saline served as controls. Wound biopsies were taken on days 6, 8, 10, and 12 for
histological evaluation. Wound ﬂuid was exchanged every 24 hours and evaluated using a
totalproteinELISA. Biopsieswere stainedwithH&E forevaluationofreteridgeformation
and thickness of epidermis on different biopsy days.
Animals
All animal procedures were approved by the Harvard Medical Area Standing Committee
on Animals and conformed with the regulations related to animal use and other federal
statutes. Female Yorkshire pigs (Parson’s Farm, Hadley, Massachusetts), weighing 40 to
50 kg at arrival, were allowed to acclimatize for 1 week before initiation of the experiment.
Induction of diabetes
Animals were weighed, received induction anesthesia with tiletamine HCl and zolazepam
HCl (Telazol) (10 mg/kg BW, Wyeth Madison, New Jersey) and xylazine (2.5 mg/kg
BW, Xyla-Ject, Phoenix, St Josephs, Missouri), followed by general anesthesia with
isoﬂurane (Novaplus; Hospira, Lake Forest, Illinois) inhalation (2%–3% vol) and were
weighed. Streptozotocin (Zanosar; Pharmacia, Pﬁzer, New York) was applied at a dose of
150 mg/kg body weight. The solution was administered through an intravenous catheter
over1minute.Buprenorphinewasadministeredforpaincontrol.Serumglucoseconcentra-
tionwasmeasureddaily.Thepigsweretreatedwithasubcutaneousinjectionofshort-acting
insulin and long-acting insulin zinc suspension (Normulin; Novo Nordisk, Princeton, New
Jersey; Humulin; Eli Lilly, Indianapolis, Indiana) to keep the blood glucose concentration
between 350 and 550 mg/dL.
Wounding
Thedorsumofthepigswaswaxed(Nair,Church&Dwight,Princeton,NewJersey),shaved,
and thoroughly disinfected. Twenty-four squares (15 mm × 15 mm) per pig were outlined
by a tattoo machine (Special Electric Tattoo Marker; Spaulding Enterprises; Voorheesville,
New York). After the skin was prepared with povidone/iodine, the skin within the tat-
too borders was excised at a depth of 18/1000 of an inch using an electric dermatome
(Fig 1).
For all sites, medical adhesive (Hollister, Inc, Libertyville, Illinois) was brushed onto
the skin surrounding the wounds. Self-enclosed polyurethane wound chambers (Corium
International, Grand Rapids, Michigan) were sealed to the surrounding skin.
Woundingofthediabeticpigswasdone14daysafterinductionofdiabetesinthesame
fashion as described above.
Maintenance of wound ﬂuid
Wound ﬂuid was exchanged, measured, and reﬁlled daily, while the pigs were anesthetized
with tiletamine HCl and zolazepam HCl and were suspended in a Panepinto sling. The ﬂuid
was kept on ice throughout the procedure, centrifuged at 1200 rpm, ﬂash frozen, and stored
at −70◦C.
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Figure 1. A dermatome–created partial-thickness wound, covered with a
wound chamber. Close to the center of the chamber is a port, which allows
multiple injections into the wound chamber.
Total protein assay
A commercial protein assay (#23227, Pierce, Rockford, Illinois) was used as described
in the manufacturer’s protocol. The absorbance of the resulting turbidity was read by a
photospectrometer at 420 nm and compared with the protein standard similarly treated.
Histological evaluation
Diagonal biopsies, covering the whole wound, were excised from the pigs on days 6, 8, 10,
and 12. On every biopsy day, 6 wounds in each study group and 6 wounds in the control
group were excised. Biopsied wounds were excluded from further study.
Specimens were parafﬁn-embedded, cut into 6-μm sections, and stained for hema-
toxylin and eosin. Moreover, the number of rete ridges per 2.5 mm of wound surface and
the number of cell layers were evaluated.
The thickness of epidermis was measured in 10 random locations in the histologies
from the different biopsy days.
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Statistics
Means and standard errors for healing time were calculated for the groups. Statistical
signiﬁcance between groups was analyzed with the nonparametric Mann-Whitney U test.
RESULTS
Healthy pigs
Using this protocol, it was possible to get a complete set of data from 70 of the 72 wounds.
Because of disruption of the wound chambers by the pig, 2 wounds could not be evaluated
on day 10 and consequently on day 12, one in the ACCS group every other day and one
in the control group. This decreased the number of wounds in these groups on days 10
and 12 to 5 instead of 6. The pigs appeared healthy and behaved normally throughout the
experiment. There was no adverse effect from the ACCS on any wound or surrounding skin
at any time.
The macroscopic appearance of the wounds during the healing process was similar
in all groups at each time point. There was no redness or other sign of adverse side effect
in the ACCS-treated wounds. The scarring at the end point of the study was similar in all
groups and all wounds.
No difference could be shown in the total protein concentration in the wound ﬂuid
between group ACCS every 4 days and the control group. All controls were used to obtain
signiﬁcant numbers. Group ACCS every 4 days had a much higher protein concentration
due to the fact that protein was allowed to accumulate for 4 days rather than for 1 day
(Fig 2).
Figure 2. Characteristics of the protein concentration for ACCS qd and the control group based
on a daily collection and for group ACCS collected every 4th day. Note that the protein in the
wound ﬂuid from the group ACCS q4d wounds has been accumulated over 4 days and has a
different base line compared with group ACCS qd and the control, which accumulated over 1 day.





on day 6, 8, and 10. No difference could be observed by day 12 (Fig 3).
Figure 4 shows the number cell layers in the epidermis. This graph mirrors the results
shown in Figure 3. The grid used for selecting the point of measurement was the same in
both experiments but no attempt was made to measure in exactly the same place. It should
also be pointed out that the cells are rounder and thicker on day 6 than on day 12, which
explains why the lower numbers of cells on day 6 do not correlate with a signiﬁcantly
thinner epidermis.
Figure 3. Thickness of the epidermis in histological sections on biopsy days 6, 8, 10, and 12
inhealthypigs.A,ACCSq4d;B,ACCSqod;andC,control.ACCSindicatesamnion-derived
cellular cytokine solution.
Figure 4. Number of cell layers on biopsy days 6, 8, 10, and 12 in healthy pigs. A, ACCS
q4d; B, ACCS qd; and C, control. ACCS indicates amnion-derived cellular cytokine solution.
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Figure 5. Thickness of epidermis in diabetic pigs (A: 0.455-mL ACCS/cm2, B: 0.255-mL
ACCS/cm2, D: 0.111-mL ACCS/cm2, E: 0.045-mL ACCS/cm2, F: 0.022-mL ACCS/cm2,C :
Control)
The evaluation of rete ridges per 2.5 mm showed, except for group ACCS every 4 days
on day 10, a consistently and signiﬁcantly larger number of rete ridges in groups ACCS
every 4 days and ACCS every day as compared with the control group (Fig 9).
Diabetic pigs
Summarizing the histological data, including thickness of the epithelium, number of cell
layers in the newly formed epithelium, and rete formation, we recognized numeric differ-
ences. More epidermal cell layers and thicker epidermis were found at all concentrations
of ACCS compared with the saline control (Figs 5–8). Moreover, the rete formation in the
ACCS groups was higher than in the control.
ELISA evaluation of the wound ﬂuid showed an increase of the protein concentration
in the ﬁrst days followed by a drop between days 4 and 6. The protein concentration of
the last days (7–12) remained stable (Fig 7). Similar data could be shown in the previous
experiments on healthy pigs.
DISCUSSION
Cells in culture secrete factors that may provide support to or affect the growth, differen-
tiation, and protein production of other cells.9 Stem cells and stem cell–like multipotent
cells are known to produce cytokine growth factors that serve as mediators to the cellular
processes of the wound-healing scheme.3 Normal wound healing is accomplished by a
combination of cytokines, and they occur in a “natural” cascade.11 ACCS has been shown
to have cytokines at physiological levels including PDGF, VEGF, angiogenin, TGF-β2,
TIMP-1, and TIMP-2.9 Applying ACCS in a continuous “wet” environment accelerated
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Figure 6. Layersofepidermisindiabeticpigs(A:0.455-mLACCS/cm2,B:0.255-mLACCS/cm2,
D: 0.111-mL ACCS/cm2, E: 0.045-mL ACCS/cm2, F: 0.022-mL ACCS/cm2, C: control).
Figure 7. Total protein concentration in wound ﬂuid of diabetic pigs (A: 0.455-mL ACCS/cm2,
B: 0.255-mL ACCS/cm2, D: 0.111-mL ACCS/cm2, E: 0.045-mL ACCS/cm2, F: 0.022-mL
ACCS/cm2, C: control).
and improved healing in the 2 experiments in both normal and diabetic swine. Maturation
ofthehealedepidermiswasacceleratedbothmacroscopically(Fig10)andmicroscopically.
Comparing the thickness of the epidermis, the layers of the epidermis, or the rete ridge
formation in both experiments demonstrated ACCS improvement versus saline control. It
did not seem to matter the frequency of application, or the dose of ACCS chosen. Even the
smallest dose, 0.022 mL/cm2 of ACCS showed the improvement (Figs 6, 7, and 8).
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Figure 8. Number of rete ridges per 2.5 mm on biopsy days 6, 8, 10, and 12 in diabetic pigs
(A: 0.455-mL ACCS/cm2, B: 0.255-mL ACCS/cm2, D: 0.111-mL ACCS/cm2, E: 0.045-mL
ACCS/cm2, F: 0.022-mL ACCS/cm2, C: control).
Figure 9. Number of rete ridges per 2.5 mm on biopsy days 6, 8, 10, and 12 in healthy pigs
(A: ACCS q4d, B: ACCS qod, C: control).
There was very little difference in the healing of partial-thickness donor site wounds
in the diabetic swine versus the normal swine. This is not surprising. The model presents
the ideal situation for reepithelialization with a “wet” environment, chambers to prevent
inﬂammation and/or infection, and a dermal base, which does not require keratinocyte
migration. Although more than 100 physiological factors contribute to wound-healing
deﬁciencies in individuals with diabetes, it has not been shown that reepithelialization of a
partial-thickness wound in an ideal protected environment is impaired.12,13
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Figure 10. Macroscopic pictures of representative wounds on days 6 and 10 in diabetic pigs:
(a) day 6, 0.455-mL ACCS/cm2; (b) day 6, control; (c) day 10, 0.455-mL ACCS/cm2; and (d) day
10, control. ACCS indicates amnion-derived cellular cytokine solution.
In conclusion, ACCS has been demonstrated to accelerate and/or improve wound
healing in acute and chronic wound models,1 mesh graft interstices,14 and now in
partial-thickness donor site wounds. A clinical trial is now under way to evaluate its safety
and efﬁcacy in human wounds.
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